With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Elders Ltd (ASX: ELD)
According to a note out of Bell Potter, its analysts have retained their buy rating on this agribusiness company's shares with an improved price target of $9.45. Bell Potter believes that continued ACCC delays on the proposed Delta Agribusiness transaction is masking improved pricing trends and seasonal outlooks in the base business. It highlights that there has been a material acceleration in crop input and livestock pricing indicators and an improved seasonal outlook. All in all, the broker believes this leaves Elders well-placed to deliver double digit earnings per share growth through to FY 2027. It then estimates that the Delta acquisition has scope to be ~10% accretive to FY 2026 earnings per share. The Elders share price is trading at $7.50 on Monday.
GQG Partners Inc (ASX: GQG)
A note out of Macquarie reveals that its analysts have retained their outperform rating on this fund manager's shares with a reduced price target of $2.64. This follows the release of a funds under management update which revealed a disappointing decline due partly to a $1 billion single institutional client outflow. But with GQG's portfolios remaining defensively positioned, resulting in all strategies underperforming their respective benchmarks in 2025, the broker feels this could potentially be a headwind for future net flows. Nevertheless, at under 8x forward earnings and with a double-digit forecast dividend yield, the broker feels that its shares are too cheap to ignore. The GQG Partners share price is fetching $1.80 at the time of writing.
QBE Insurance Group Ltd (ASX: QBE)
Analysts at Citi have retained their buy rating on this insurance giant's shares with an improved price target of $26.20. According to the note, the broker believes that share price weakness since the release of its half year results has been an overreaction. It feels that conservative practices were behind softer than expected guidance. In addition, the broker highlights that QBE Insurance's CAT allowances appear to be conservative, which could mean positive outcomes despite higher than average global CAT activity. Overall, the broker has boosted its earnings estimates and valuation accordingly to reflect this. The QBE share price is trading at $21.11 on Monday.
